docpepper
New Member
Thought some of you guys might find this interesting. The company who created PT-141 (Bremelanotide) just finished Phase 2 trials studying the combo of PT-141 + Tirz for obesity. Data expected later this quarter according to the press release. Something interesting to look out for.
palatin.com
They're also trying to make an oral melanocortin-4 agonist (mechanism of action for MT-2 and PT-141), and a weekly injectable MC4 agonist, both for obesity. They're really pushing the obesity with this thing. If you only the FDA would be cool with MT-2 + Tirz. Overnight bestseller that would rip chicks out of high-waisted jeans and into bikinis.
I'm familar with MT2 but not PT-141. Anyone have some thoughts on this, happens to know a little about what's going on at Palatin?
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide | Palatin Technologies
Feb 06, 2025, 07:30 ET Last Patient / Last Visit Completed Topline Data Readout Expected Later This QuarterCRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Pala ...

They're also trying to make an oral melanocortin-4 agonist (mechanism of action for MT-2 and PT-141), and a weekly injectable MC4 agonist, both for obesity. They're really pushing the obesity with this thing. If you only the FDA would be cool with MT-2 + Tirz. Overnight bestseller that would rip chicks out of high-waisted jeans and into bikinis.
I'm familar with MT2 but not PT-141. Anyone have some thoughts on this, happens to know a little about what's going on at Palatin?